[The clinical studies on midecamycin granules in the otorhinolaryngological field (author's transl)].
Clinical investigation with a new macrolide antibiotic, midecamycin granules was performed with the results which may lead to the following conclusion. 1) Results of clinical treatment: When midecamycin granules were administered orally in 31 cases of representative infections in the otorhinolaryngological field, it was excellent in 7 cases, good in 20 cases, fair in one case and poor in 3 cases. When the cases in which it was excellent and good were considered together, good results were obtained in 27 cases, that is a ratio of effectiveness of 87.1 per cent. 2) Side effect: No side effect was shown with the oral administration of midecamycin granules.
D000208:Acute Disease; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004304:Dosage Forms; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D005260:Female; D005667:Furunculosis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007933:Leucomycins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D010033:Otitis Media / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010309:Parotitis / Q000188:drug therapy; D014069:Tonsillitis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D004304:Dosage Forms; D007933:Leucomycins